ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) |
Grant Type |
Year | State |
|---|---|---|---|---|
| Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma | Dana-Farber Cancer Institute / Riaz Gillani, MD | Young Investigator Grants | 2021 | Massachusetts |
| Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies | Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD | Young Investigator Grants | 2021 | Ohio |
| Targeting EZHIP as a therapeutic strategy for infantile ependymomas | University of Wisconsin - Madison / Peter Lewis, PhD | Innovation Grants | 2021 | Wisconsin |
| Role of H3.3-G34R mutation in pediatric high-grade glioma | University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD | Innovation Grants | 2021 | Texas |
| Targeting tumor associated macrophages in metastatic Ewing sarcoma (ES) | New York Medical College / Mitchell Cairo, MD | Innovation Grants | 2021 | New York |
| In-vivo characterization of MYCN-driven immunosuppression | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2021 | California |
| Hematopoietic stem cell function in familial platelet disorder therapy | University of Massachusetts Medical School / Lucio Castilla, PhD | Innovation Grants | 2021 | Massachusetts |
| Phosphopeptides as shared targets for donor derived T cell therapy of AML | Memorial Sloan-Kettering Cancer Center / Richard O'Reilly, MD | Innovation Grants | 2021 | New York |
| Loss of ER-mitochondria contacts drives therapy resistance in neuroblastoma | Children’s Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2021 | Pennsylvania |
| Targeting CCAAT/enhancer binding proteins CEBPB and CEBPD in neuroblastoma | Columbia University / Darrell Yamashiro, MD/PhD | Innovation Grants | 2021 | New York |